Precision Medicine for Childhood Cancer: Current Limitations and Future Perspectives

Martin G McCabe1, Birgit Geoerger2, Louis Chesler3,4

  • 1Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom.

JCO Precision Oncology
|January 11, 2024
PubMed

Insights

Greater collaboration is essential to unlock the full potential of molecular profiling initiatives for treating pediatric cancers. Enhanced data sharing and interdisciplinary efforts are key to advancing precision oncology for children.

Area of Science:

  • Oncology
  • Genomics
  • Pediatric Medicine

Background:

  • Molecular profiling has emerged as a powerful tool in understanding cancer biology.
  • Pediatric cancers present unique challenges and require tailored therapeutic strategies.
  • Current molecular profiling initiatives show promise but face hurdles in data integration and collaboration.

Purpose of the Study:

  • To highlight the critical need for enhanced collaboration in pediatric cancer molecular profiling.
  • To underscore the potential of integrated molecular data for improving treatment outcomes.
  • To identify barriers and facilitators for successful collaborative efforts.

Main Methods:

  • Review of current molecular profiling initiatives in pediatric oncology.
  • Analysis of data-sharing practices and collaborative frameworks.
  • Synthesis of expert opinions on optimizing research efforts.

Main Results:

  • Significant potential exists within molecular profiling initiatives to advance pediatric cancer care.
  • Lack of standardized data-sharing protocols and interdisciplinary collaboration hinders progress.
  • Successful implementation requires dedicated infrastructure and policy support.

Conclusions:

  • Enhanced collaboration among researchers, clinicians, and institutions is paramount.
  • A unified approach to molecular profiling will accelerate the development of targeted therapies for pediatric cancers.
  • Investment in collaborative platforms is crucial for realizing the full benefits of precision medicine in pediatric oncology.

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
332